Clinical Trials Browser

Glioblastoma × Interleukin-13 × 90 days × Clear all

NCT04003649 2026-05-14

IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM

Phase 1 Active not recruiting

Glioblastoma